Valuation: Novoprotein Scientific Inc.

Market Cap 9.28B 1.39B 1.24B 1.15B 1.04B 1.95B 131B 1.98B 13.75B 5.39B 68.94B 5.21B 5.11B 220B P/E 2024
-42.6x
P/E 2025 -36.1x
Enterprise Value 7.63B 1.14B 1.02B 942M 853M 1.61B 108B 1.63B 11.3B 4.43B 56.65B 4.28B 4.2B 181B EV / Sales 2024
4.57x
EV / Sales 2025 7.78x
Free-Float
30.99%
Yield 2024 *
-
Yield 2025 -
1 day+2.45%
1 week-2.67%
Current month-16.77%
1 month+34.81%
3 months+264.26%
6 months+165.41%
Current year+233.33%
1 week 123.8
Extreme 123.8
159.99
1 month 115.27
Extreme 115.27
168.03
Current year 33.2
Extreme 33.2
168.03
1 year 33.2
Extreme 33.2
168.03
3 years 28.56
Extreme 28.56
168.03
5 years 28.56
Extreme 28.56
168.03
10 years 28.56
Extreme 28.56
168.03
Manager TitleAgeSince
Chief Executive Officer 54 2009-09-06
Director of Finance/CFO 53 2013-06-30
Chief Tech/Sci/R&D Officer 36 2015-06-30
Director TitleAgeSince
Chairman 54 2009-09-06
Director/Board Member 54 2019-01-31
Director/Board Member 41 2021-04-14
Change 5-day change 1-year change 3-year change Capi.($)
+2.45%-2.67%+227.37%+179.23% 1.36B
-1.01%+5.13%+58.93%+120.37% 1,144B
-0.61%+1.52%+34.34%+70.28% 625B
-1.48%+0.47%+23.08%+96.78% 511B
+0.54%+8.95%+39.45%+64.02% 377B
+1.07%+1.70%+71.06%+45.02% 366B
+0.30%+6.35%+21.84%+49.62% 291B
-0.03%+6.04%+0.40%+20.94% 262B
-0.14%+2.87%+45.56%+60.53% 237B
-1.88%+0.02%+23.77%+98.00% 194B
Average -0.07%+4.51%+54.58%+80.48% 400.93B
Weighted average by Cap. -0.47%+6.90%+40.85%+81.13%

Financials

2024 2025
Net sales 128M 19.1M 17.02M 15.76M 14.26M 26.87M 1.8B 27.19M 189M 74.15M 948M 71.66M 70.17M 3.02B 146M 21.93M 19.54M 18.09M 16.37M 30.85M 2.07B 31.22M 217M 85.12M 1.09B 82.27M 80.56M 3.47B
Net income -54.42M -8.15M -7.26M -6.72M -6.08M -11.46M -769M -11.6M -80.62M -31.63M -404M -30.57M -29.94M -1.29B -77.78M -11.65M -10.38M -9.61M -8.7M -16.39M -1.1B -16.58M -115M -45.22M -578M -43.7M -42.79M -1.84B
Net Debt -1.73B -260M -232M -214M -194M -365M -24.52B -370M -2.57B -1.01B -12.89B -975M -954M -41.07B -1.65B -248M -221M -204M -185M -349M -23.38B -353M -2.45B -962M -12.29B -929M -910M -39.16B
Projected Income Statement - Annual - Novoprotein Scientific Inc.
Logo Novoprotein Scientific Inc.
Novoprotein Scientific Inc is a China-based company mainly engaged in the provision of recombinant protein application solutions. The Company’s main businesses include the research and development, production and sales of target and factor proteins, recombinant antibodies, enzymes and reagents, and the provision of full process application solutions in the fields of biopharmaceuticals, in vitro diagnostics, and basic research in life sciences. The Company's main products include novel coronavirus diagnostic antibodies, novel coronavirus diagnostic antigens, novel coronavirus pseudoviruses, novel coronavirus non-structural proteins and messenger ribonucleic acid (mRNA) raw materials enzymes and reagents. Its products and services are mainly used in biological medicine, basic research of life science, in vitro diagnosis, mRNA vaccine drugs and other fields. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
696
Date Price Change Volume
26-10-20 CN¥133.50 +2.45% 6,498,948
26-10-20 CN¥130.31 -1.53% 6,050,443
26-10-19 CN¥132.34 -5.07% 7,716,160
26-10-16 CN¥139.41 -7.79% 8,181,936
26-10-15 CN¥151.18 +5.57% 7,583,243
  1. Stock Market
  2. Stocks
  3. 688137 Stock